Rep. David Taylor Sells Off Shares of Lam Research Corporation (NASDAQ:LRCX)

Key Points

• Representative David Taylor sold shares of Lam Research Corporation (NASDAQ:LRCX) worth between $1,001 and $15,000 on July 18th, 2025.
• Lam Research recently reported quarterly earnings of $1.33 EPS, exceeding expectations, along with a 33.6% year-over-year revenue increase.
• The company announced a quarterly dividend increase to $0.26 per share, reflecting a long-term growth strategy with an annual yield of 1.1%.

Representative David Taylor (R-Ohio) recently sold shares of Lam Research Corporation (NASDAQ:LRCX). In a filing disclosed on September 02nd, the Representative disclosed that they had sold between $1,001 and $15,000 in Lam Research stock on July 18th. The trade occurred in the Representative's "DAVID TAYLOR TRUST > SCHWAB JOINT BROKERAGE #1 (HOME GROWN)" account.

Representative David Taylor also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 8/14/2025.
• Purchased $1,001 - $15,000 in shares of Marathon Petroleum NYSE: MPC on 8/14/2025.
• Purchased $15,001 - $50,000 in shares of Eli Lilly and Company NYSE: LLY on 8/14/2025.
• Purchased $1,001 - $15,000 in shares of Prologis NYSE: PLD on 8/14/2025.
• Purchased $1,001 - $15,000 in shares of Visa NYSE: V on 8/13/2025.
• Purchased $1,001 - $15,000 in shares of Procter & Gamble NYSE: PG on 8/13/2025.
• Sold $1,001 - $15,000 in shares of Installed Building Products NYSE: IBP on 8/13/2025.
• Purchased $1,001 - $15,000 in shares of Salesforce NYSE: CRM on 8/7/2025.
• Purchased $1,001 - $15,000 in shares of Prologis NYSE: PLD on 8/7/2025.
• Purchased $1,001 - $15,000 in shares of Procter & Gamble NYSE: PG on 8/7/2025.

Lam Research Trading Up 0.7%

Shares of NASDAQ LRCX opened at $97.74 on Thursday. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $108.02. The stock has a market cap of $123.70 billion, a P/E ratio of 23.50, a price-to-earnings-growth ratio of 1.29 and a beta of 1.76. The firm has a 50-day moving average of $99.68 and a 200 day moving average of $85.60. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.21 by $0.12. The company had revenue of $5.17 billion during the quarter, compared to analysts' expectations of $4.99 billion. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. Lam Research's revenue was up 33.6% on a year-over-year basis. During the same period last year, the company posted $1.03 EPS. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. As a group, sell-side analysts expect that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th will be given a dividend of $0.26 per share. This is an increase from Lam Research's previous quarterly dividend of $0.23. The ex-dividend date of this dividend is Wednesday, September 24th. This represents a $1.04 dividend on an annualized basis and a yield of 1.1%. Lam Research's dividend payout ratio is 22.12%.

Analysts Set New Price Targets

LRCX has been the subject of several recent analyst reports. Argus lifted their target price on shares of Lam Research from $105.00 to $120.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Citigroup lifted their target price on shares of Lam Research from $108.00 to $113.00 and gave the stock a "buy" rating in a report on Friday, August 1st. KeyCorp lifted their target price on shares of Lam Research from $105.00 to $115.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. Wall Street Zen raised shares of Lam Research from a "hold" rating to a "buy" rating in a report on Saturday, August 2nd. Finally, Needham & Company LLC lifted their target price on shares of Lam Research from $110.00 to $115.00 and gave the stock a "buy" rating in a report on Thursday, July 31st. Twenty analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Lam Research currently has an average rating of "Moderate Buy" and a consensus price target of $107.22.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Smallwood Wealth Investment Management LLC purchased a new position in shares of Lam Research during the first quarter valued at approximately $26,000. IMG Wealth Management Inc. bought a new stake in Lam Research during the second quarter valued at approximately $26,000. Mpwm Advisory Solutions LLC bought a new stake in Lam Research during the fourth quarter valued at approximately $27,000. Howard Hughes Medical Institute bought a new stake in Lam Research during the second quarter valued at approximately $27,000. Finally, Strategic Wealth Investment Group LLC bought a new stake in Lam Research during the second quarter valued at approximately $29,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

About Representative Taylor

David Taylor (Republican Party) is a member of the U.S. House, representing Ohio's 2nd Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Taylor (Republican Party) ran for election to the U.S. House to represent Ohio's 2nd Congressional District. He won in the general election on November 5, 2024. David Taylor graduated from Amelia High School. Taylor earned degrees from Miami University (Ohio) and the University of Dayton School of Law. Taylor's career experience includes working as an attorney and as a businessman at Sardinia Ready Mix, Inc.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.